<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2023-16-3-173-179</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-1317</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Телемедицина для глаукомы: современное состояние и тенденции развития</article-title><trans-title-group xml:lang="en"><trans-title>Telemedicine for glaucoma: the state-of-the-art and trends of development</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6922-0464</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петров</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrov</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сергей Юрьевич Петров - д-р мед. наук, начальник отдела глаукомы</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Sergey Yu. Petrov - Dr. of Med. Sci., head, department of glaucoma</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><email xlink:type="simple">glaucomatosis@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3679-8619</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малишевская</surname><given-names>Т. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Malishevskaya</surname><given-names>T. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Татьяна Николаевна Малишевская - д-р мед. наук, заведующая отделением аналитической работы</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Tatiana N. Malishevskaya - Dr. of Med. Sci., head, department of analytics</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фарикова</surname><given-names>Э. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Farikova</surname><given-names>E. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Эльмаз Эльдаровна Фарикова - врач-офтальмолог</p><p>ул. Льва Толстого, д. 6–8, Санкт-Петербург, 197022</p></bio><bio xml:lang="en"><p>Elmaz E. Farikova - ophthalmologist</p><p>6-8, Leo Tolstoy St., St. Petersburg, 197022</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8090-6034</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маркелова</surname><given-names>О. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Markelova</surname><given-names>O. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Оксана Игоревна Маркелова - аспирант отдела глаукомы</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Oksana I. Markelova - post-graduate student</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ глазных болезней им. Гельмгольца» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Helmholtz National Medical Research Center of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.P.Pavlov First St. Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>12</day><month>10</month><year>2023</year></pub-date><volume>16</volume><issue>3</issue><fpage>173</fpage><lpage>179</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Петров С.Ю., Малишевская Т.Н., Фарикова Э.Э., Маркелова О.И., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Петров С.Ю., Малишевская Т.Н., Фарикова Э.Э., Маркелова О.И.</copyright-holder><copyright-holder xml:lang="en">Petrov S.Y., Malishevskaya T.N., Farikova E.E., Markelova O.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/1317">https://roj.igb.ru/jour/article/view/1317</self-uri><abstract><p>Глаукома занимает первое место среди причин инвалидности вследствие офтальмопатологии практически во всех регионах России. Это хроническое пожизненное заболевание, при котором мониторинг (раз в год или чаще) осуществляется в условиях медицинского учреждения. По мере старения населения распространенность глаукомы неуклонно растет, в связи с чем доступ к медицинской помощи становится более ограниченным. Прогресс в сфере телекоммуникаций и диагностических технологий позволил разработать программы телеглаукомы, в рамках которых основные метрические данные, касающиеся глаукомы, передаются дистанционному специалисту для интерпретации. Федеральный закон № 242-ФЗ о телемедицине вступил в силу с 1 января 2018 г., но пандемия COVID-19 значительно ускорила развитие информационных технологий в медицине в целом и телемедицинской коммуникации в частности. В данном обзоре представлены сведения, касающиеся программ телеглаукомы, которые свидетельствуют об их эффективности, и практические рекомендации. Потенциально телемедицинские коммуникации способны улучшить доступ к медицинской помощи. Результаты анализа экономической составляющей показали, что дистанционный прием более эффективен с экономической точки зрения, чем очное обследование пациента. При использовании программ телеглаукомы достаточно часто выявляются глаукоматозные изменения диска зрительного нерва и значительное число пациентов с подозрением на глаукому направляются на скрининг. Публикации, посвященные опыту использования активных прог рамм, способствуют их дальнейшему развитию и внедрению в общественное здравоохранение, что позволит расширить доступ к качественной медицинской помощи больным с глаукомой.</p></abstract><trans-abstract xml:lang="en"><p>Glaucoma is the top leading cause of ophthalmic-related disability in almost all Russian regions. It is a chronic lifelong disease which requires regular monitoring (once a year or more often) in a medical facility. Since the population is aging, the prevalence of glaucoma is steadily increasing, which hampers access to medical care. Advances in telecommunications and diagnostic technologies have given rise to programs of TV glaucoma, which are used to pass the basic glaucoma parameters on to a specialist working remotely for interpretation. The Federal Law No 242-FZ on telemedicine came into force on January 1, 2018, but the COVID-19 pandemic sped up the development of information technologies in medicine in general and telemedicine communication in particular. The review presents the data on TV glaucoma programs which point to their effectiveness and provides practical advice. Potentially, telemedicine can facilitate access to medical care. The analysis of the economic factors shows that remote consulting is more cost-effective than traditional face-to-face examination of the patient. TV glaucoma programs often help detect glaucomatous changes in the ONH, so more patients with suspicion of glaucoma are referred for screening.. Publications focused on the experience in using active programs contribute to their further development and introduction to the public health system, which will eventually facilitate the access to quality medical care for patients with glaucoma.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>глаукома</kwd><kwd>медицинская помощь</kwd><kwd>информационные технологии</kwd><kwd>диагностические технологии</kwd><kwd>телекоммуникации</kwd><kwd>телемедицина</kwd><kwd>телеглаукома</kwd></kwd-group><kwd-group xml:lang="en"><kwd>glaucoma</kwd><kwd>medical care</kwd><kwd>information technologies</kwd><kwd>diagnostic technologies</kwd><kwd>telecommunications</kwd><kwd>telemedicine</kwd><kwd>TV glaucoma</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121 (11): 2081-90. doi: 10.1016/j.ophtha.2014.05.013</mixed-citation><mixed-citation xml:lang="en">Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121 (11): 2081-90. doi: 10.1016/j.ophtha.2014.05.013</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Заболеваемость всего населения России в 2020 году с диагнозом, установленным впервые в жизни. Министерство здравоохранения Российской Федерации, ФГБУ «Центральный научно-исследовательский институт организации и информатизации здравоохранения». Москва; 2021.</mixed-citation><mixed-citation xml:lang="en">The incidence of the entire population of Russia in 2020 with a diagnosis established for the first time in life. Ministry of health of the Russian Federation, Central research institute of health organization and informatization. Moscow; 2021 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Статистические данные ФГБУ «Федеральное бюро медико-социальной экспертизы Минтруда России»; 2020–2021 гг.</mixed-citation><mixed-citation xml:lang="en">Statistics data of Federal bureau of medical and social expertise of the Ministry of Labor of Russia; 2020–2021 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Canadian Ophthalmological Society Glaucoma Clinical Practice Guideline Expert Committee; Canadian Ophthalmological Society. Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye. Can J Ophthalmol. 2009; 44 Suppl 1: S7–93. doi: 10.3129/cjo44s1</mixed-citation><mixed-citation xml:lang="en">Canadian Ophthalmological Society Glaucoma Clinical Practice Guideline Expert Committee; Canadian Ophthalmological Society. Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye. Can J Ophthalmol. 2009; 44 Suppl 1: S7–93. doi: 10.3129/cjo44s1</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Prum BE, Jr, Rosenberg LF, Gedde SJ, et al. Primary Open-Angle Glaucoma Preferred Practice Pattern (R) Guidelines. Ophthalmology. 2016; 123 (1): 41–111. doi: 10.1016/j.ophtha.2015.10.053</mixed-citation><mixed-citation xml:lang="en">Prum BE, Jr, Rosenberg LF, Gedde SJ, et al. Primary Open-Angle Glaucoma Preferred Practice Pattern (R) Guidelines. Ophthalmology. 2016; 123 (1): 41–111. doi: 10.1016/j.ophtha.2015.10.053</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Heffler M. The future of telehealth. Evolving COVID perspectives offer clues. Pharmaceutical executive. 2021; 41 (4): 34–36.</mixed-citation><mixed-citation xml:lang="en">Heffler M. The future of telehealth. Evolving COVID perspectives offer clues. Pharmaceutical executive. 2021; 41 (4): 34–36.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Howland C, Despins L, Sindt J, Wakefield B, Mehr DR. Primary care clinic nurse activities with a telehealth monitoring system. West J Nurs Res. 2020; 43 (1): 5–12. doi: 10.1177/0193945920923082</mixed-citation><mixed-citation xml:lang="en">Howland C, Despins L, Sindt J, Wakefield B, Mehr DR. Primary care clinic nurse activities with a telehealth monitoring system. West J Nurs Res. 2020; 43 (1): 5–12. doi: 10.1177/0193945920923082</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Resnikoff S, Felch W, Gauthier TM, Spivey B. The number of ophthalmologists in practice and training worldwide: a growing gap despite more than 200,000 practitioners. Br J Ophthalmol. 2012; 96 (6): 783–7. doi: 10.1136/bjophthalmol-2011-301378</mixed-citation><mixed-citation xml:lang="en">Resnikoff S, Felch W, Gauthier TM, Spivey B. The number of ophthalmologists in practice and training worldwide: a growing gap despite more than 200,000 practitioners. Br J Ophthalmol. 2012; 96 (6): 783–7. doi: 10.1136/bjophthalmol-2011-301378</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kassam F, Yogesan K, Sogbesan E, Pasquale LR, Damji KF. Teleglaucoma: improving access and efficiency for glaucoma care. Middle East Afr J Ophthalmol. 2013; 20 (2): 142–9. doi: 10.4103/0974-9233.110619</mixed-citation><mixed-citation xml:lang="en">Kassam F, Yogesan K, Sogbesan E, Pasquale LR, Damji KF. Teleglaucoma: improving access and efficiency for glaucoma care. Middle East Afr J Ophthalmol. 2013; 20 (2): 142–9. doi: 10.4103/0974-9233.110619</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Blazquez F, Sebastian MA, Anton A. Detection of glaucoma using SisGlaTel: acceptability and satisfaction among participants, and problems detected. Arch Soc Esp Oftalmol. 2008; 83 (9): 533–8. doi: 10.4321/s0365-66912008000900005</mixed-citation><mixed-citation xml:lang="en">Blazquez F, Sebastian MA, Anton A. Detection of glaucoma using SisGlaTel: acceptability and satisfaction among participants, and problems detected. Arch Soc Esp Oftalmol. 2008; 83 (9): 533–8. doi: 10.4321/s0365-66912008000900005</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Clarke J, Puertas R, Kotecha A, Foster PJ, Barton K. Virtual clinics in glaucoma care: face-to-face versus remote decision-making. Br J Ophthalmol. 2017; 101 (7): 892–5. doi: 10.1136/bjophthalmol-2016-308993</mixed-citation><mixed-citation xml:lang="en">Clarke J, Puertas R, Kotecha A, Foster PJ, Barton K. Virtual clinics in glaucoma care: face-to-face versus remote decision-making. Br J Ophthalmol. 2017; 101 (7): 892–5. doi: 10.1136/bjophthalmol-2016-308993</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">de Bont A, Bal R. Telemedicine in interdisciplinary work practices: on an IT system that met the criteria for success set out by its sponsors, yet failed to become part of every-day clinical routines. BMC Med Inform Decis Mak. 2008; 8: 47. doi: 10.1186/1472-6947-8-47</mixed-citation><mixed-citation xml:lang="en">de Bont A, Bal R. Telemedicine in interdisciplinary work practices: on an IT system that met the criteria for success set out by its sponsors, yet failed to become part of every-day clinical routines. BMC Med Inform Decis Mak. 2008; 8: 47. doi: 10.1186/1472-6947-8-47</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hautala N, Hyytinen P, Saarela V, et al. A mobile eye unit for screening of diabetic retinopathy and follow-up of glaucoma in remote locations in northern Finland. Acta Ophthalmol. 2009; 87 (8): 912–3. doi: 10.1111/j.1755-3768.2009.01570.x</mixed-citation><mixed-citation xml:lang="en">Hautala N, Hyytinen P, Saarela V, et al. A mobile eye unit for screening of diabetic retinopathy and follow-up of glaucoma in remote locations in northern Finland. Acta Ophthalmol. 2009; 87 (8): 912–3. doi: 10.1111/j.1755-3768.2009.01570.x</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kassam F, Amin S, Sogbesan E, Damji KF. The use of teleglaucoma at the University of Alberta. J Telemed Telecare. 2012; 18 (7): 367–73. doi: 10.1258/jtt.2012.120313</mixed-citation><mixed-citation xml:lang="en">Kassam F, Amin S, Sogbesan E, Damji KF. The use of teleglaucoma at the University of Alberta. J Telemed Telecare. 2012; 18 (7): 367–73. doi: 10.1258/jtt.2012.120313</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Keenan J, Shahid H, Bourne RR, White AJ, Martin KR. Cambridge community Optometry Glaucoma Scheme. Clin Exp Ophthalmol. 2015; 43 (3): 221–7. doi: 10.1111/ceo.12398</mixed-citation><mixed-citation xml:lang="en">Keenan J, Shahid H, Bourne RR, White AJ, Martin KR. Cambridge community Optometry Glaucoma Scheme. Clin Exp Ophthalmol. 2015; 43 (3): 221–7. doi: 10.1111/ceo.12398</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kennedy C, Kirwan J, Cook C, et al. Telemedicine techniques can be used to facilitate the conduct of multicentre trials. J Telemed Telecare. 2000; 6 (6): 343–7; discussion 347-9. doi: 10.1258/1357633001936030</mixed-citation><mixed-citation xml:lang="en">Kennedy C, Kirwan J, Cook C, et al. Telemedicine techniques can be used to facilitate the conduct of multicentre trials. J Telemed Telecare. 2000; 6 (6): 343–7; discussion 347-9. doi: 10.1258/1357633001936030</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kiage D, Kherani IN, Gichuhi S, Damji KF, Nyenze M. The Muranga Teleophthalmology Study: comparison of virtual (teleglaucoma) with in-person clinical assessment to diagnose glaucoma. Middle East Afr J Ophthalmol. 2013; 20 (2): 150–7. doi: 10.4103/0974-9233.110604</mixed-citation><mixed-citation xml:lang="en">Kiage D, Kherani IN, Gichuhi S, Damji KF, Nyenze M. The Muranga Teleophthalmology Study: comparison of virtual (teleglaucoma) with in-person clinical assessment to diagnose glaucoma. Middle East Afr J Ophthalmol. 2013; 20 (2): 150–7. doi: 10.4103/0974-9233.110604</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Li HK, Tang RA, Oschner K, et al. Telemedicine screening of glaucoma. Telemed J. 1999; 5 (3): 283–290. doi: 10.1089/107830299312032</mixed-citation><mixed-citation xml:lang="en">Li HK, Tang RA, Oschner K, et al. Telemedicine screening of glaucoma. Telemed J. 1999; 5 (3): 283–290. doi: 10.1089/107830299312032</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Owsley C, Rhodes LA, McGwin G, Jr, et al. Eye Care Quality and Accessibility Improvement in the Community (EQUALITY) for adults at risk for glaucoma: study rationale and design. Int J Equity Health. 2015; 14: 135. doi: 10.1186/s12939-015-0213-8</mixed-citation><mixed-citation xml:lang="en">Owsley C, Rhodes LA, McGwin G, Jr, et al. Eye Care Quality and Accessibility Improvement in the Community (EQUALITY) for adults at risk for glaucoma: study rationale and design. Int J Equity Health. 2015; 14: 135. doi: 10.1186/s12939-015-0213-8</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Staffieri SE, Ruddle JB, Kearns LS, et al. Telemedicine model to prevent blindness from familial glaucoma. Clin Exp Ophthalmol. 2011; 39 (8): 760–5. doi: 10.1111/j.1442-9071.2011.02556.x</mixed-citation><mixed-citation xml:lang="en">Staffieri SE, Ruddle JB, Kearns LS, et al. Telemedicine model to prevent blindness from familial glaucoma. Clin Exp Ophthalmol. 2011; 39 (8): 760–5. doi: 10.1111/j.1442-9071.2011.02556.x</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Tuulonen A, Ohinmaa T, Alanko HI, et al. The application of teleophthalmology in examining patients with glaucoma: a pilot study. J Glaucoma. 1999; 8 (6): 367–73. https://pubmed.ncbi.nlm.nih.gov/10604295/</mixed-citation><mixed-citation xml:lang="en">Tuulonen A, Ohinmaa T, Alanko HI, et al. The application of teleophthalmology in examining patients with glaucoma: a pilot study. J Glaucoma. 1999; 8 (6): 367–73. https://pubmed.ncbi.nlm.nih.gov/10604295/</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Verma S, Arora S, Kassam F, Edwards MC, Damji KF. Northern Alberta remote teleglaucoma program: clinical outcomes and patient disposition. Can J Ophthalmol. 2014; 49 (2): 135–40. doi: 10.1016/j.jcjo.2013.11.005</mixed-citation><mixed-citation xml:lang="en">Verma S, Arora S, Kassam F, Edwards MC, Damji KF. Northern Alberta remote teleglaucoma program: clinical outcomes and patient disposition. Can J Ophthalmol. 2014; 49 (2): 135–40. doi: 10.1016/j.jcjo.2013.11.005</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Wright HR, Diamond JP. Service innovation in glaucoma management: using a Web-based electronic patient record to facilitate virtual specialist supervision of a shared care glaucoma programme. Br J Ophthalmol. 2015; 99 (3): 313–7. doi: 10.1136/bjophthalmol-2014-305588</mixed-citation><mixed-citation xml:lang="en">Wright HR, Diamond JP. Service innovation in glaucoma management: using a Web-based electronic patient record to facilitate virtual specialist supervision of a shared care glaucoma programme. Br J Ophthalmol. 2015; 99 (3): 313–7. doi: 10.1136/bjophthalmol-2014-305588</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kotecha A, Baldwin A, Brookes J, Foster PJ. Experiences with developing and implementing a virtual clinic for glaucoma care in an NHS setting. Clin Ophthalmol. 2015; 9: 1915–23. doi: 10.2147/OPTH.S92409</mixed-citation><mixed-citation xml:lang="en">Kotecha A, Baldwin A, Brookes J, Foster PJ. Experiences with developing and implementing a virtual clinic for glaucoma care in an NHS setting. Clin Ophthalmol. 2015; 9: 1915–23. doi: 10.2147/OPTH.S92409</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Court JH, Austin MW. Virtual glaucoma clinics: patient acceptance and quality of patient education compared to standard clinics. Clin Ophthalmol. 2015; 9: 745–9. doi: 10.2147/OPTH.S75000</mixed-citation><mixed-citation xml:lang="en">Court JH, Austin MW. Virtual glaucoma clinics: patient acceptance and quality of patient education compared to standard clinics. Clin Ophthalmol. 2015; 9: 745–9. doi: 10.2147/OPTH.S75000</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Cavallerano AA, Cavallerano JD, Katalinic P, et al. A telemedicine program for diabetic retinopathy in a Veterans Affairs Medical Center — the Joslin Vision Network Eye Health Care Model. Am J Ophthalmol. 2005; 139 (4): 597–604. doi: 10.1016/j.ajo.2004.10.064</mixed-citation><mixed-citation xml:lang="en">Cavallerano AA, Cavallerano JD, Katalinic P, et al. A telemedicine program for diabetic retinopathy in a Veterans Affairs Medical Center — the Joslin Vision Network Eye Health Care Model. Am J Ophthalmol. 2005; 139 (4): 597–604. doi: 10.1016/j.ajo.2004.10.064</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Park DW, Mansberger SL. Eye disease in patients with diabetes screened with telemedicine. Telemed J E Health. 2017; 23 (2): 113–8. doi: 10.1089/tmj.2016.0034</mixed-citation><mixed-citation xml:lang="en">Park DW, Mansberger SL. Eye disease in patients with diabetes screened with telemedicine. Telemed J E Health. 2017; 23 (2): 113–8. doi: 10.1089/tmj.2016.0034</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Elson MJ, Giangiacomo A, Maa AY, et al. Early Experience with full-scope shared-care teleglaucoma in Canada. J Glaucoma. 2022; 31 (2): 79–83. doi: 10.1097/IJG.0000000000001905</mixed-citation><mixed-citation xml:lang="en">Elson MJ, Giangiacomo A, Maa AY, et al. Early Experience with full-scope shared-care teleglaucoma in Canada. J Glaucoma. 2022; 31 (2): 79–83. doi: 10.1097/IJG.0000000000001905</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Thomas SM, Jeyaraman MM, Hodge WG, et al. The effectiveness of teleglaucoma versus in-patient examination for glaucoma screening: a systematic review and meta-analysis. PLoS One. 2014; 9 (12): e113779. doi: 10.1371/journal.pone.0113779</mixed-citation><mixed-citation xml:lang="en">Thomas SM, Jeyaraman MM, Hodge WG, et al. The effectiveness of teleglaucoma versus in-patient examination for glaucoma screening: a systematic review and meta-analysis. PLoS One. 2014; 9 (12): e113779. doi: 10.1371/journal.pone.0113779</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Moyer V. Force U.S.P.S.T. Screening for glaucoma: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2013; 159 (7): 484–9. doi: 10.7326/0003-4819-159-6-201309170-00686</mixed-citation><mixed-citation xml:lang="en">Moyer V. Force U.S.P.S.T. Screening for glaucoma: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2013; 159 (7): 484–9. doi: 10.7326/0003-4819-159-6-201309170-00686</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Bokman CL, Pasquale LR, Parrish RK, 2nd, Lee RK. Glaucoma screening in the Haitian Afro-Caribbean population of South Florida. PLoS One. 2014; 9 (12): e115942. doi: 10.1371/journal.pone.0115942</mixed-citation><mixed-citation xml:lang="en">Bokman CL, Pasquale LR, Parrish RK, 2nd, Lee RK. Glaucoma screening in the Haitian Afro-Caribbean population of South Florida. PLoS One. 2014; 9 (12): e115942. doi: 10.1371/journal.pone.0115942</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Waisbourd M, Pruzan NL, Johnson D, et al. The Philadelphia glaucoma detection and treatment project: Detection rates and initial management. Ophthalmology. 2016; 123 (8): 1667–74. doi: 10.1016/j.ophtha.2016.04.031</mixed-citation><mixed-citation xml:lang="en">Waisbourd M, Pruzan NL, Johnson D, et al. The Philadelphia glaucoma detection and treatment project: Detection rates and initial management. Ophthalmology. 2016; 123 (8): 1667–74. doi: 10.1016/j.ophtha.2016.04.031</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Kassam F, Sogbesan E, Boucher S, et al. Collaborative care and teleglaucoma: a novel approach to delivering glaucoma services in Northern Alberta, Canada. Clin Exp Optom. 2013; 96 (6): 577–580. doi: 10.1111/cxo.12065</mixed-citation><mixed-citation xml:lang="en">Kassam F, Sogbesan E, Boucher S, et al. Collaborative care and teleglaucoma: a novel approach to delivering glaucoma services in Northern Alberta, Canada. Clin Exp Optom. 2013; 96 (6): 577–580. doi: 10.1111/cxo.12065</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kashiwagi K, Tanabe N, Go K, et al. Comparison of a remote operating slitlamp microscope system with a conventional slit-lamp microscope system for examination of trabeculectomy eyes. J Glaucoma. 2013; 22 (4): 278–83. doi: 10.1097/IJG.0b013e318239c343</mixed-citation><mixed-citation xml:lang="en">Kashiwagi K, Tanabe N, Go K, et al. Comparison of a remote operating slitlamp microscope system with a conventional slit-lamp microscope system for examination of trabeculectomy eyes. J Glaucoma. 2013; 22 (4): 278–83. doi: 10.1097/IJG.0b013e318239c343</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Астахов Ю.С., Тургель В.А. Телемедицина в офтальмологии. Часть 1. Общая телеофтальмология. Офтальмологические ведомости. 2020; 13 (1): 43–52.</mixed-citation><mixed-citation xml:lang="en">Astakhov Y.S., Turgel V.A. Telemedicine in ophthalmology. Part 1. Common teleophthalmology. Ophthalmology Journal. 2020; 13 (1): 43–52 (In Russ.). doi: 10.17816/OV19112</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Астахов Ю.С., Тургель В.А. Телемедицина в офтальмологии. Часть 2. Частная телеофтальмология. Офтальмологические ведомости. 2020; 13 (3): 67–80.</mixed-citation><mixed-citation xml:lang="en">Astakhov Y.S., Turgel V.A. Telemedicine in ophthalmology. Part 2. Particular teleophthalmology. Ophthalmology Journal. 2020; 13 (3): 67-–80 (In Russ.). doi: 10.17816/OV46314</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Icare Finland. Application “Icare PATIENT”. Available at: https://patients.icare-world.com/</mixed-citation><mixed-citation xml:lang="en">Icare Finland. Application “Icare PATIENT”. Available at: https://patients.icare-world.com/</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Glaucare GmbH. Application “Glaucare”. Available at: https://glau.care/en/</mixed-citation><mixed-citation xml:lang="en">Glaucare GmbH. Application “Glaucare”. Available at: https://glau.care/en/</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Responsum Health. Application “The Glaucoma Community”. Available at: https://responsumhealth.com/glaucoma/2022</mixed-citation><mixed-citation xml:lang="en">Responsum Health. Application “The Glaucoma Community”. Available at: https://responsumhealth.com/glaucoma/2022</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">IPADE — Instituto para o Desenv. da Educa o LTDA. Application “GlaucoCheck”. Available at: https://play.google.com/store/apps/details?id=com.lit.glaucocheck</mixed-citation><mixed-citation xml:lang="en">IPADE — Instituto para o Desenv. da Educa o LTDA. Application “GlaucoCheck”. Available at: https://play.google.com/store/apps/details?id=com.lit.glaucocheck</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Lanue Startup. Application “Glaucoma SPIA”. Available at: https://apkpure.com/br/glaucoma-spia-triagem/appinventor.ai_diego_santiagomarinho. GlaucomaSpIA_Triagem</mixed-citation><mixed-citation xml:lang="en">Lanue Startup. Application “Glaucoma SPIA”. Available at: https://apkpure.com/br/glaucoma-spia-triagem/appinventor.ai_diego_santiagomarinho. GlaucomaSpIA_Triagem</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Johannes Vegt. Application “Glaucoma”. Available at: https://play.google.com/store/apps/details?id=de.signsberlin.glaucoma&amp;hl=en_US</mixed-citation><mixed-citation xml:lang="en">Johannes Vegt. Application “Glaucoma”. Available at: https://play.google.com/store/apps/details?id=de.signsberlin.glaucoma&amp;hl=en_US</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">АО «КазНИИ глазных болезней». Application «Глаукома». Available at: https://play.google.com/store/apps/details?id=com.gluacomaalmaty.glaucoma&amp;hl=ru&amp;gl=US</mixed-citation><mixed-citation xml:lang="en">АО «КазНИИ глазных болезней». Application «Глаукома». Available at: https://play.google.com/store/apps/details?id=com.gluacomaalmaty.glaucoma&amp;hl=ru&amp;gl=US</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Hmtl bureau. Application «Тонометрия по Маклакову». Available at: https://play.google.com/store/apps/details?id=com.ngse.tonometry</mixed-citation><mixed-citation xml:lang="en">Hmtl bureau. Application «Тонометрия по Маклакову». Available at: https:// play.google.com/store/apps/details?id=com.ngse.tonometry</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Казанов Юрий. Available at: Application «GlauHint». Available at: https://play.google.com/store/apps/details?id=com.Kazanov.GlauHint</mixed-citation><mixed-citation xml:lang="en">Казанов Юрий. Available at: Application «GlauHint». Available at: https:// play.google.com/store/apps/details?id=com.Kazanov.GlauHint</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Казанова С.Ю., Казанов Ю.А. Цифровые технологии в лечении глаукомы. Национальный журнал Глаукома. 2020; 19 (4): 12–9. Kazanova S. u.,</mixed-citation><mixed-citation xml:lang="en">Kazanov Yu.A. Digital technologies for the treatment of glaucoma. National Journal glaucoma. 2020; 19 (4): 12–19 (In Russ.). doi: 10.25700/NJG.2020.04.02</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Liu S, Lam S, Weinreb RN, et al. Comparison of standard automated perimetry, frequency-doubling technology perimetry, and short-wavelength automated perimetry for detection of glaucoma. Invest Ophthalmol Vis Sci. 2011; 52 (10): 7325–31. doi: 10.1167/iovs.11-7795</mixed-citation><mixed-citation xml:lang="en">Liu S, Lam S, Weinreb RN, et al. Comparison of standard automated perimetry, frequency-doubling technology perimetry, and short-wavelength automated perimetry for detection of glaucoma. Invest Ophthalmol Vis Sci. 2011; 52 (10): 7325–31. doi: 10.1167/iovs.11-7795</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Monsalve B, Ferreras A, Calvo P, et al. Diagnostic ability of Humphrey perimetry, Octopus perimetry, and optical coherence tomography for glaucomatous optic neuropathy. Eye (Lond). 2017; 31 (3): 443–51. doi: 10.1038/eye.2016.251</mixed-citation><mixed-citation xml:lang="en">Monsalve B, Ferreras A, Calvo P, et al. Diagnostic ability of Humphrey perimetry, Octopus perimetry, and optical coherence tomography for glaucomatous optic neuropathy. Eye (Lond). 2017; 31 (3): 443–51. doi: 10.1038/eye.2016.251</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Lowry EA, Hou J, Hennein L, et al. Comparison of Peristat online perimetry with the Humphrey perimetry in a clinic-based setting. Transl Vis Sci Technol. 2016; 5 (4): 4. doi: 10.1167/tvst.5.4.4</mixed-citation><mixed-citation xml:lang="en">Lowry EA, Hou J, Hennein L, et al. Comparison of Peristat online perimetry with the Humphrey perimetry in a clinic-based setting. Transl Vis Sci Technol. 2016; 5 (4): 4. doi: 10.1167/tvst.5.4.4</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Vingrys AJ, Healey JK, Liew S, et al. Validation of a tablet as a tangent perimeter. Transl Vis Sci Technol. 2016; 5 (4): 3. doi: 10.1167/tvst.5.4.3</mixed-citation><mixed-citation xml:lang="en">Vingrys AJ, Healey JK, Liew S, et al. Validation of a tablet as a tangent perimeter. Transl Vis Sci Technol. 2016; 5 (4): 3. doi: 10.1167/tvst.5.4.3</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Tojo N, Abe S, Ishida M, Yagou T, Hayashi A. The fluctuation of intraocular pressure measured by a contact lens sensor in normal tension glaucoma patients and nonglaucoma subjects. J Glaucoma. 2017; 26 (3): 195–200. doi: 10.1097/IJG.0000000000000517</mixed-citation><mixed-citation xml:lang="en">Tojo N, Abe S, Ishida M, Yagou T, Hayashi A. The fluctuation of intraocular pressure measured by a contact lens sensor in normal tension glaucoma patients and nonglaucoma subjects. J Glaucoma. 2017; 26 (3): 195–200. doi: 10.1097/IJG.0000000000000517</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Tojo N, Hayashi A, Otsuka M, Miyakoshi A. Fluctuations of the intraocular pressure in pseudoexfoliation syndrome and normal eyes measured by a contact lens sensor. J Glaucoma. 2016; 25 (5): e463–468. doi: 10.1097/IJG.0000000000000292</mixed-citation><mixed-citation xml:lang="en">Tojo N, Hayashi A, Otsuka M, Miyakoshi A. Fluctuations of the intraocular pressure in pseudoexfoliation syndrome and normal eyes measured by a contact lens sensor. J Glaucoma. 2016; 25 (5): e463–468. doi: 10.1097/IJG.0000000000000292</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Brandt JD, Beiser JA, Gordon MO, Kass MA. Ocular Hypertension Treatment Study G. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study. Am J Ophthalmol. 2004; 138 (5): 717–22. doi: 10.1016/j.ajo.2004.07.036</mixed-citation><mixed-citation xml:lang="en">Brandt JD, Beiser JA, Gordon MO, Kass MA. Ocular Hypertension Treatment Study G. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study. Am J Ophthalmol. 2004; 138 (5): 717–22. doi: 10.1016/j.ajo.2004.07.036</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Tan S, Yu M, Baig N, Hansapinyo L, Tham CC. Agreement of patient-measured intraocular pressure using rebound tonometry with Goldmann applanation tonometry (GAT) in glaucoma patients. Sci Rep. 2017; 7: 42067. doi: 10.1038/srep42067</mixed-citation><mixed-citation xml:lang="en">Tan S, Yu M, Baig N, Hansapinyo L, Tham CC. Agreement of patient-measured intraocular pressure using rebound tonometry with Goldmann applanation tonometry (GAT) in glaucoma patients. Sci Rep. 2017; 7: 42067. doi: 10.1038/srep42067</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Han JW, Cho SY, Kang KD. Correlation between optic nerve parameters obtained using 3D nonmydriatic retinal camera and optical coherence tomography: Interobserver agreement on the disc damage likelihood scale. J Ophthalmol. 2014; 2014: 931738. doi: 10.1155/2014/931738</mixed-citation><mixed-citation xml:lang="en">Han JW, Cho SY, Kang KD. Correlation between optic nerve parameters obtained using 3D nonmydriatic retinal camera and optical coherence tomography: Interobserver agreement on the disc damage likelihood scale. J Ophthalmol. 2014; 2014: 931738. doi: 10.1155/2014/931738</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Spaeth GL, Henderer J, Liu C, et al. The disc damage likelihood scale: reproducibility of a new method of estimating the amount of optic nerve damage caused by glaucoma. Trans Am Ophthalmol Soc. 2002; 100: 181–5; discussion 185-186. PMID: 12545692</mixed-citation><mixed-citation xml:lang="en">Spaeth GL, Henderer J, Liu C, et al. The disc damage likelihood scale: reproducibility of a new method of estimating the amount of optic nerve damage caused by glaucoma. Trans Am Ophthalmol Soc. 2002; 100: 181–5; discussion 185-186. PMID: 12545692</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Schrems WA, Schrems-Hoesl LM, Mardin CY, et al. Can glaucomatous visual field progression be predicted by structural and functional measures? J Glaucoma. 2017; 26 (4): 373–82. doi: 10.1097/IJG.0000000000000628</mixed-citation><mixed-citation xml:lang="en">Schrems WA, Schrems-Hoesl LM, Mardin CY, et al. Can glaucomatous visual field progression be predicted by structural and functional measures? J Glaucoma. 2017; 26 (4): 373–82. doi: 10.1097/IJG.0000000000000628</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Li G, Fansi AK, Boivin JF, Joseph L, Harasymowycz P. Screening for glaucoma in high-risk populations using optical coherence tomography. Ophthalmology. 2010; 117 (3): 453–61. doi: 10.1016/j.ophtha.2009.07.033</mixed-citation><mixed-citation xml:lang="en">Li G, Fansi AK, Boivin JF, Joseph L, Harasymowycz P. Screening for glaucoma in high-risk populations using optical coherence tomography. Ophthalmology. 2010; 117 (3): 453–61. doi: 10.1016/j.ophtha.2009.07.033</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Springelkamp H, Lee K, Wolfs RC, et al. Population-based evaluation of retinal nerve fiber layer, retinal ganglion cell layer, and inner plexiform layer as a diagnostic tool for glaucoma. Invest Ophthalmol Vis Sci. 2014; 55 (12): 8428–38. doi: 10.1167/iovs.14-15506</mixed-citation><mixed-citation xml:lang="en">Springelkamp H, Lee K, Wolfs RC, et al. Population-based evaluation of retinal nerve fiber layer, retinal ganglion cell layer, and inner plexiform layer as a diagnostic tool for glaucoma. Invest Ophthalmol Vis Sci. 2014; 55 (12): 8428–38. doi: 10.1167/iovs.14-15506</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Chong GT, Lee RK. Glaucoma versus red disease: imaging and glaucoma diagnosis. Curr Opin Ophthalmol. 2012; 23 (2): 79–88. doi: 10.1097/ICU.0b013e32834ff431</mixed-citation><mixed-citation xml:lang="en">Chong GT, Lee RK. Glaucoma versus red disease: imaging and glaucoma diagnosis. Curr Opin Ophthalmol. 2012; 23 (2): 79–88. doi: 10.1097/ICU.0b013e32834ff431</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Haleem MS, Han L, Hemert J, et al. Regional image features model for automatic classification between normal and glaucoma in fundus and Scanning Laser Ophthalmoscopy (SLO) images. J Med Syst. 2016; 40 (6): 132. doi: 10.1007/s10916-016-0482-9</mixed-citation><mixed-citation xml:lang="en">Haleem MS, Han L, Hemert J, et al. Regional image features model for automatic classification between normal and glaucoma in fundus and Scanning Laser Ophthalmoscopy (SLO) images. J Med Syst. 2016; 40 (6): 132. doi: 10.1007/s10916-016-0482-9</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Thomas S, Hodge W, Malvankar-Mehta M. The cost-effectiveness analysis of teleglaucoma screening device. PLoS One. 2015; 10 (9): e0137913. doi: 10.1371/journal.pone.0137913</mixed-citation><mixed-citation xml:lang="en">Thomas S, Hodge W, Malvankar-Mehta M. The cost-effectiveness analysis of teleglaucoma screening device. PLoS One. 2015; 10 (9): e0137913. doi: 10.1371/journal.pone.0137913</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">O'Day R, Smith C, Muir J, Turner A. Optometric use of a teleophthalmology service in rural Western Australia: comparison of two prospective audits. Clin Exp Optom. 2016; 99 (2): 163–7. doi: 10.1111/cxo.12334</mixed-citation><mixed-citation xml:lang="en">O'Day R, Smith C, Muir J, Turner A. Optometric use of a teleophthalmology service in rural Western Australia: comparison of two prospective audits. Clin Exp Optom. 2016; 99 (2): 163–7. doi: 10.1111/cxo.12334</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Gan K, Liu Y, Stagg B, et al. Telemedicine for glaucoma: Guidelines and recommendations. Telemed J E Health. 2020; 26 (4): 551–5. doi: 10.1089/tmj.2020.0009</mixed-citation><mixed-citation xml:lang="en">Gan K, Liu Y, Stagg B, et al. Telemedicine for glaucoma: Guidelines and recommendations. Telemed J E Health. 2020; 26 (4): 551–5. doi: 10.1089/tmj.2020.0009</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
